Seattle Genetics | Obroty



Sales Zmiana Data
AbbVie USD 13.34B 1.76B 2025-03
Acadia Pharmaceuticals USD 244.32M 15.28M 2025-03
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Amgen USD 8.15B 936M 2025-03
Astellas Pharma JPY 459.29B 58.12B 2025-03
Bayer EUR 13.74B 2.01B 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Celldex Therapeutics USD 1.18M 5K 2025-03
Daiichi Sankyo JPY 518.69B 33.85B 2025-03
Eisai JPY 188.24B 27.9B 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Exelixis USD 555.4M 11.35M 2025-03
Genmab DKK 5.28B 59.13B 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
Incyte USD 1.05B 128.7M 2025-03
Insmed USD 92.82M 11.62M 2025-03
MacroGenics USD 19.35M 91.35M 2024-12
Merck USD 15.53B 94M 2025-03
Moderna USD 108M 858M 2025-03
Novartis USD 13.15B 330M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Sanofi EUR 9.9B 660M 2025-03
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Takeda JPY 1.05T 90B 2025-03
Teva Pharmaceutical Industries USD 14.06B 1.27B 2025-03
Vertex Pharmaceuticals USD 2.77B 142M 2025-03
Xencor USD 32.73M 37.29M 2025-03



Seattle Genetics Obroty - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.